| scholarly article | Q13442814 |
| P2093 | author name string | Xian-Tao Song | |
| Kefeng Li | |||
| Jing-Hua Liu | |||
| Song Cui | |||
| Guo-Lin Ma | |||
| Shu-Zheng Lv | |||
| Li-Jun Meng | |||
| Ben-Jun Du | |||
| Quan-Sheng Gao | |||
| P2860 | cites work | Blockade of keratinocyte-derived chemokine inhibits endothelial recovery and enhances plaque formation after arterial injury in ApoE-deficient mice. | Q50488486 |
| A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells. | Q51207735 | ||
| Endothelial progenitor cell mobilization after percutaneous coronary intervention | Q61634451 | ||
| Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model | Q67733219 | ||
| Fabrication of endothelial progenitor cell (EPC)-seeded intravascular stent devices and in vitro endothelialization on hybrid vascular tissue | Q73280851 | ||
| Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation | Q74482103 | ||
| Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions | Q24313124 | ||
| Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells | Q24315277 | ||
| Endoglin forms a heteromeric complex with the signaling receptors for transforming growth factor-beta | Q24336809 | ||
| Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells | Q24337230 | ||
| Identification of distinct epitopes of endoglin, an RGD-containing glycoprotein of endothelial cells, leukemic cells, and syncytiotrophoblasts | Q28186129 | ||
| Coronary-artery stents | Q28295059 | ||
| Vascular responses to drug eluting stents: importance of delayed healing | Q28302959 | ||
| Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications | Q34576422 | ||
| Role of the endothelium in modulating neointimal formation: vasculoprotective approaches to attenuate restenosis after percutaneous coronary interventions | Q35863530 | ||
| TGF-beta receptor function in the endothelium. | Q36017194 | ||
| Endoglin modulates cellular responses to TGF-beta 1. | Q36236945 | ||
| Drug-eluting stents: preventing restenosis | Q36685771 | ||
| Approaches for prevention of restenosis | Q37039843 | ||
| Endoglin (CD105): a marker of tumor vasculature and potential target for therapy | Q37125562 | ||
| Anti-inflammatory effect of abciximab-coated stent in a porcine coronary restenosis model | Q37221177 | ||
| Endothelial progenitor cell (EPC) capture to aid vascular repair following coronary stenting: a new frontier in stent technology? | Q37388505 | ||
| Late stent thrombosis, endothelialisation and drug-eluting stents | Q37472938 | ||
| Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours | Q37610628 | ||
| Neutrophil-derived cathelicidin protects from neointimal hyperplasia | Q40000791 | ||
| Atrogin-1/muscle atrophy F-box inhibits calcineurin-dependent cardiac hypertrophy by participating in an SCF ubiquitin ligase complex | Q40177208 | ||
| Bone marrow-derived progenitor cells modulate vascular reendothelialization and neointimal formation: effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition | Q40697868 | ||
| Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury | Q42443808 | ||
| Two-year clinical registry follow-up of endothelial progenitor cell capture stent versus sirolimus-eluting bioabsorbable polymer-coated stent versus bare metal stents in patients undergoing primary percutaneous coronary intervention for ST elevation | Q43126317 | ||
| Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor | Q43157373 | ||
| Anti-CD34 antibodies immobilized on the surface of sirolimus-eluting stents enhance stent endothelialization | Q43175040 | ||
| Mobilization of endothelial progenitor cells in patients with acute myocardial infarction | Q43636896 | ||
| Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells | Q44039853 | ||
| The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating concepts | Q44905265 | ||
| Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry | Q46489660 | ||
| Late stent thrombosis after drug-eluting stent implantation for acute myocardial infarction: a new red flag is raised | Q47356923 | ||
| Delayed arterial healing and increased late stent thrombosis at culprit sites after drug-eluting stent placement for acute myocardial infarction patients: an autopsy study | Q47382463 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 428619 | |
| P577 | publication date | 2014-05-04 | |
| P1433 | published in | BioMed Research International | Q17509958 |
| P1476 | title | A novel stent coated with antibodies to endoglin inhibits neointimal formation of porcine coronary arteries | |
| P478 | volume | 2014 |
| Q35535453 | Comparison of reendothelialization and neointimal formation with stents coated with antibodies against endoglin and CD34 in a porcine model |
| Q39127466 | Effects of amniotic epithelial cell transplantation in endothelial injury. |
| Q35779631 | In vitro Study of a Novel Stent Coating Using Modified CD39 Messenger RNA to Potentially Reduce Stent Angioplasty-Associated Complications |
| Q87681974 | TGF-β Signaling in Control of Cardiovascular Function |
Search more.